Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3052% above fair value
$10.57−0.69 (-6.13%)
Close on Nov 20, 2026Market cap $233.65MP/E –Yield –
Amarin free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Amarin's free cash flow for the twelve months ending Dec 31, 2020 was -$22.00M. For fiscal 2020 it was -$22.00M. The highest annual figure on record is -$11.84M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -$22.00M | – |
| FY2019 | Dec 31, 2019 | -$11.84M | – |
| FY2018 | Dec 31, 2018 | -$94.76M | – |
| FY2017 | Dec 31, 2017 | -$32.85M | – |
| FY2016 | Dec 31, 2016 | -$71.84M | – |
| FY2015 | Dec 31, 2015 | -$84.05M | – |
| FY2013 | Dec 31, 2013 | -$190.35M | – |
| FY2012 | Dec 31, 2012 | -$122.85M | – |
| FY2011 | Dec 31, 2011 | -$39.84M | – |
| FY2010 | Dec 31, 2010 | -$33.89M | – |
| FY2009 | Dec 31, 2009 | -$28.52M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | -$38.32M | – |
| Q3 FY2020 | Sep 30, 2020 | $10.85M | -46.9% |
| Q2 FY2020 | Jun 30, 2020 | $1.59M | – |
| Q1 FY2020 | Mar 31, 2020 | $3.89M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.30M | – |
| Q3 FY2019 | Sep 30, 2019 | $20.44M | – |
| Q4 FY2018 | Dec 31, 2018 | -$32.31M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.14M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.28M | – |
| Q2 FY2017 | Jun 30, 2017 | -$10.50M | – |
| Q1 FY2017 | Mar 31, 2017 | -$13.93M | – |
| Q4 FY2016 | Dec 31, 2016 | -$19.31M | – |
See a number that looks wrong?